- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ganetespib
Total 35 results
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States, Canada
-
Emory UniversitySynta Pharmaceuticals Corp.CompletedRectal CancerUnited States
-
University College, LondonCancer Research UKCompletedLung Cancer - Malignant Pleural MesotheliomaUnited Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompleted
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Synta Pharmaceuticals Corp.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | AML | CML | ALL | Blast-phase Chronic Myelogenous LeukemiaUnited States
-
Synta Pharmaceuticals Corp.UnknownSolid TumorsUnited States
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
UCB Biopharma S.P.R.L.CompletedFocal-Onset Seizures | Drug-resistant EpilepsyUnited States, Australia, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Lithuania, Mexico, Poland, Portugal, Slovakia, Spain, Turkey, United Kingdom
-
David M. Jackman, MDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Synta Pharmaceuticals...CompletedSmall Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
Synta Pharmaceuticals Corp.CompletedGastrointestinal Stromal TumorUnited States
-
University of FloridaCompleted
-
UCB Biopharma SRLCompletedGeneralized Myasthenia GravisUnited States, Canada, Czechia, Denmark, France, Germany, Italy, Japan, Poland, Russian Federation, Spain, Taiwan
-
UCB Biopharma SRLCompletedGeneralized Myasthenia GravisUnited States, Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Serbia, Spain, Taiwan, United Kingdom
-
Emory UniversitySynta Pharmaceuticals Corp.TerminatedStage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage I Hypopharyngeal Squamous Cell Carcinoma | Stage I Laryngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II... and other conditionsUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Post-traumatic Stress DisorderUnited States
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Cardiff UniversityExperimental Cancer Medicine Centres; Leukaemia & Lymphoma Research GroupCompletedHigh Risk Myelodysplastic Syndrome | Acute Myeloid LeukaemiaUnited Kingdom
-
Georgetown UniversitySynta Pharmaceuticals Corp.TerminatedCancer | Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAdvanced Lung CancerUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
National Cancer Institute (NCI)Terminated
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; Synta Pharmaceuticals Corp.CompletedSarcoma | Malignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Emory UniversitySynta Pharmaceuticals Corp.; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenEuropean CommissionCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaGermany, Belgium, Italy, Austria, France
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
ShireCompleted
-
University of ChicagoWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States